The Trustee of the 9685 Trust – Trademark Portfolio
Entity Type: 17
The Trustee of the 9685 Trust holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include NYC HERBS. The owner is based in New York, NY.
2248 Broadway
Suite 1215
New York, NY 10024
Showing of trademarks Trademarks
Trademark Classifications
The Trustee of the 9685 Trust's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does The Trustee of the 9685 Trust have?
The Trustee of the 9685 Trust has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does The Trustee of the 9685 Trust file in?
The Trustee of the 9685 Trust files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 35 covers advertising; business management; business administration; office functions.
What are The Trustee of the 9685 Trust's most well-known trademarks?
The Trustee of the 9685 Trust's registered trademark portfolio includes well-known marks such as NYC HERBS. These are among 1 currently registered trademark in the portfolio.
What is The Trustee of the 9685 Trust's trademark registration success rate?
The Trustee of the 9685 Trust has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.